SE419443B - PROCEDURE FOR PREPARING NEW 2,4 DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVES - Google Patents
PROCEDURE FOR PREPARING NEW 2,4 DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVESInfo
- Publication number
- SE419443B SE419443B SE7411382A SE7411382A SE419443B SE 419443 B SE419443 B SE 419443B SE 7411382 A SE7411382 A SE 7411382A SE 7411382 A SE7411382 A SE 7411382A SE 419443 B SE419443 B SE 419443B
- Authority
- SE
- Sweden
- Prior art keywords
- diamino
- procedure
- preparing new
- benzylpyrimidine derivatives
- benzylpyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
- C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1305773A CH591456A5 (en) | 1973-09-12 | 1973-09-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7411382L SE7411382L (en) | 1975-03-13 |
| SE419443B true SE419443B (en) | 1981-08-03 |
Family
ID=4388903
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7411382A SE419443B (en) | 1973-09-12 | 1974-09-09 | PROCEDURE FOR PREPARING NEW 2,4 DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVES |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS6042238B2 (en) |
| AR (2) | AR207764A1 (en) |
| AT (1) | AT338797B (en) |
| BE (1) | BE819773A (en) |
| BR (1) | BR7407614D0 (en) |
| CA (1) | CA1037476A (en) |
| CH (1) | CH591456A5 (en) |
| CU (1) | CU34115A (en) |
| DD (2) | DD122785A5 (en) |
| DE (1) | DE2443682C2 (en) |
| DK (1) | DK135683B (en) |
| ES (7) | ES429949A1 (en) |
| FI (1) | FI58638C (en) |
| FR (1) | FR2242984B1 (en) |
| GB (3) | GB1484482A (en) |
| HK (1) | HK181A (en) |
| HU (1) | HU170427B (en) |
| IE (1) | IE40523B1 (en) |
| IL (1) | IL45510A (en) |
| LU (1) | LU70878A1 (en) |
| NL (1) | NL155827B (en) |
| NO (1) | NO140858C (en) |
| PH (1) | PH10643A (en) |
| PL (2) | PL99159B1 (en) |
| SE (1) | SE419443B (en) |
| SU (3) | SU577987A3 (en) |
| YU (3) | YU217874A (en) |
| ZA (1) | ZA745317B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4515948A (en) * | 1973-09-12 | 1985-05-07 | Hoffmann-La Roche Inc. | 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines |
| JPS5481278A (en) * | 1977-10-18 | 1979-06-28 | Wellcome Found | Manufacture of triiseccaminomethane |
| CH639273A5 (en) * | 1978-09-12 | 1983-11-15 | Hoffmann La Roche | DIURETIC MEANS. |
| DE3250132C2 (en) * | 1981-11-09 | 1997-01-16 | Mallinckrodt Veterinary Inc | 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn. |
| CH664960A5 (en) * | 1981-11-09 | 1988-04-15 | Wellcome Found | METHOD FOR PRODUCING SUBSTITUTED 2,4-DIAMINO-5-BENZYLPYRIMIDINES. |
| GB2180836A (en) * | 1985-09-27 | 1987-04-08 | William James Stephen Barker | Sunscreen |
| JPH0431685Y2 (en) * | 1987-06-01 | 1992-07-30 | ||
| CA1300166C (en) * | 1987-12-03 | 1992-05-05 | Alfredo Guerrato | Process for the preparation of a benzoic acid ester |
| US4900859A (en) * | 1987-12-03 | 1990-02-13 | Hoffman-La Roche Inc. | Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1103931B (en) * | 1957-02-21 | 1961-04-06 | Wellcome Found | Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives |
| US3485840A (en) * | 1964-11-12 | 1969-12-23 | Hoffmann La Roche | 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes |
-
1973
- 1973-09-12 CH CH1305773A patent/CH591456A5/xx not_active IP Right Cessation
-
1974
- 1974-01-01 AR AR255569A patent/AR207764A1/en active
- 1974-08-06 YU YU02178/74A patent/YU217874A/en unknown
- 1974-08-19 ZA ZA00745317A patent/ZA745317B/en unknown
- 1974-08-21 IL IL45510A patent/IL45510A/en unknown
- 1974-08-21 CA CA207,509A patent/CA1037476A/en not_active Expired
- 1974-09-02 FI FI2561/74A patent/FI58638C/en active
- 1974-09-03 NL NL7411685.A patent/NL155827B/en not_active IP Right Cessation
- 1974-09-04 DK DK468374AA patent/DK135683B/en unknown
- 1974-09-06 PL PL1974195308A patent/PL99159B1/en unknown
- 1974-09-06 PL PL1974173909A patent/PL97757B1/en unknown
- 1974-09-09 PH PH16253A patent/PH10643A/en unknown
- 1974-09-09 SE SE7411382A patent/SE419443B/en unknown
- 1974-09-09 IE IE1870/74A patent/IE40523B1/en unknown
- 1974-09-10 JP JP49103536A patent/JPS6042238B2/en not_active Expired
- 1974-09-10 FR FR7430568A patent/FR2242984B1/fr not_active Expired
- 1974-09-10 LU LU70878A patent/LU70878A1/xx unknown
- 1974-09-10 DD DD190238A patent/DD122785A5/xx unknown
- 1974-09-10 DD DD181015A patent/DD116824A5/xx unknown
- 1974-09-11 ES ES429949A patent/ES429949A1/en not_active Expired
- 1974-09-11 AT AT735174A patent/AT338797B/en not_active IP Right Cessation
- 1974-09-11 GB GB47893/76A patent/GB1484482A/en not_active Expired
- 1974-09-11 SU SU7402058406A patent/SU577987A3/en active
- 1974-09-11 HU HUHO1718A patent/HU170427B/hu not_active IP Right Cessation
- 1974-09-11 GB GB47894/76A patent/GB1484483A/en not_active Expired
- 1974-09-11 CU CU34115A patent/CU34115A/en unknown
- 1974-09-11 NO NO743271A patent/NO140858C/en unknown
- 1974-09-11 BE BE148396A patent/BE819773A/en not_active IP Right Cessation
- 1974-09-11 GB GB39617/74A patent/GB1484481A/en not_active Expired
- 1974-09-12 BR BR7614/74A patent/BR7407614D0/en unknown
- 1974-09-12 DE DE2443682A patent/DE2443682C2/en not_active Expired
-
1975
- 1975-04-25 ES ES437009A patent/ES437009A1/en not_active Expired
- 1975-04-25 ES ES437013A patent/ES437013A1/en not_active Expired
- 1975-04-25 ES ES437008A patent/ES437008A1/en not_active Expired
- 1975-04-25 ES ES437007A patent/ES437007A1/en not_active Expired
- 1975-04-25 ES ES437011A patent/ES437011A1/en not_active Expired
- 1975-04-25 ES ES437012A patent/ES437012A1/en not_active Expired
- 1975-06-20 SU SU7502145932A patent/SU571189A3/en active
- 1975-06-20 SU SU752145937A patent/SU609465A3/en active
- 1975-06-30 AR AR259408A patent/AR211387Q/en unknown
-
1980
- 1980-11-27 YU YU3015/80A patent/YU37153B/en unknown
- 1980-11-27 YU YU3016/80A patent/YU37154B/en unknown
-
1981
- 1981-01-08 HK HK1/81A patent/HK181A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE419981B (en) | PROCEDURE FOR PREPARING 1ALFA-HYDROXY-VITAMIN D-DERIVATE | |
| SE420201B (en) | PROCEDURE FOR PREPARING NEW 7ALFA METOXICE PHALOSPORINE DERIVATIVES | |
| SE435713B (en) | PROCEDURE FOR PREPARING 1,3-BENZOXAZOLES | |
| SE419750B (en) | PROCEDURE FOR PREPARING 6-ACYL-2,4-DIALKYL-2-HYDROXICYCLOHEXAN-1,35-TRION | |
| SE420720B (en) | PROCEDURE FOR PREPARING 2,6-DISUBSTUDE PHENYLAMINOGUANIDE COMPOUNDS | |
| SE424863B (en) | ANALOGY PROCEDURE FOR PREPARING NEW ISOQINOLINE DERIVATIVES | |
| SE420098B (en) | PROCEDURE FOR PREPARING LINKOMYCINE DERIVATIVES | |
| SE418497B (en) | PROCEDURE FOR PREPARING NEW 2,6-DISUBSTITUTED 2-PHENYLIMINOIMIDAZOLIDINES | |
| SE400074B (en) | ANALOGICAL PROCEDURE FOR PREPARING NEW TRIPEPTIDS | |
| SE419443B (en) | PROCEDURE FOR PREPARING NEW 2,4 DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVES | |
| SE420716B (en) | PROCEDURE FOR THE PREPARATION OF NEW 2-AMINOMETHYL-4,6-DIAHALOGENOPHENOLD DERIVATIVES | |
| SE430065B (en) | PROCEDURE FOR PREPARING NEW 7 ALFA METOXICE PHALOSPORINE DERIVATIVES | |
| SE416053B (en) | PROCEDURE FOR PREPARING 7ALFA-METYLOSTR-4-EN-3ALFA, 17BETA-DIOL | |
| SE419444B (en) | PROCEDURE FOR PREPARING NEW 2,4-DIAMINO-5-BENZYLPYRIMIDINE DERIVATIVES | |
| SE419543B (en) | PROCEDURE FOR PREPARING CERTAIN STATED ISOQINOLINE DERIVATIVES | |
| NO138376C (en) | PROCEDURE FOR PREPARING 1-BETA-D-RIBOFURANOSYL-1,2,4-TRIAZOLE-3-CARBOXAMIDE | |
| SE402105B (en) | PROCEDURE FOR PREPARING 2-AMINO-5-ALKYL-1,3,4-THIADIAZOLES | |
| SE419549B (en) | PROCEDURE FOR PREPARING NEW 7- (CYANOMETYLARYL) ACETAMIDOCEPHALOSPOTINE DERIVATIVES | |
| SE415100B (en) | PROCEDURE FOR PREPARING KINUCLIDINE-QUINOLINE DERIVATIVES | |
| SE401833B (en) | PROCEDURE FOR PREPARING CERTAIN STATEMENTS 1,2,4-FRIAZOLE DERIVATIVES | |
| SE417966B (en) | PROCEDURE FOR PREPARING PYRIMIDINOAMINOMETHYL-ERGOLINE DERIVATIVES | |
| SE413025B (en) | PROCEDURE FOR PREPARING NEW 6,7-BENZOMORPHANDER DERIVATIVES | |
| SE402920B (en) | PROCEDURE FOR PREPARING NEW 21-ALKYLATED 16ALFA, 17ALFA-ALKYLIDEN DIOXY-PREGN-4-EN-3,20-DIONER | |
| SE410969B (en) | PROCEDURE FOR MAKING NEW ALKYLPENYLBENZOPYRANOPYRIDINES | |
| SE7409006L (en) | PROCEDURE FOR PREPARATION OF NEW BIFENYL DERIVATIVES. |